In the Journal of the American College of Radiology: JACR, Reiner and Siegel¹ recommended 12 measures that could reduce the commoditization of radiology.

The responsibility for the phenomenon has been placed, at one time or another, on the shoulders of just about every stakeholder in the imaging field. Some say that payors are to blame; others see the growing prevalence of remote reading as the culprit. Has the expansion of IT made it possible, or is radiology merely catching up with other areas of

Do you love your job? I’m not talking about every hour of every day, waking or sleeping, rain or shine—I know that there are times when all of us get frustrated with the ebb and flow of the daily routine. Do you generally care, though, about the choice that you made at the start of your career? If you’re reading this column, you are one of roughly

To further its aim of extending subspecialty radiology services to community hospitals, Franklin & Seidelmann Subspecialty Radiology, Beachwood, Ohio, recently announced the creation of a new company called Radisphere National Radiology Group. True to its name, the group will have a national scope, with the ability to provide radiology services to

Gabe Graham, CPAThe emergence of PACS has given practices a chance to expand their business and boost revenue by tapping the rural hospital market. Before adding clients to their own networks, however, groups must pay attention to projected costs and potential profits, according to Gabe Graham, CPA, a financial consultant at Medical Management

As the potential role of informatics in transforming health care gains national attention, how are IT tools for imaging and image management evolving to improve clinical efficiency and bolster quality of care? ImagingBiz spoke with Aaron Waitz, vice president of product development for FUJIFILM Medical Systems USA, Stamford, Connecticut, on the

In a recent article in the New England Journal of Medicine, Harold C. Sox, MD, chair of the Institute of Medicine (IOM) committee to set national priorities for comparative-effectiveness research (CER), and colleagues¹ proposed a process through which the government could begin to fund research to improve medical decision making. The authors

In addition to extending coverage to an estimated 31 million US residents, the recently passed HR 3590, the Patient Protection and Affordable Care Act, has ensured a future for comparative-effectiveness research (CER) by legislating funding, at $500 million per year, for the indefinite future. The stimulus bill launched the CER initiative with seed